Last 12 months
Inside the activity.
0 purchase rows · 4 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 22, 2018 Filed May 23, 2018 20:56 UTC |
Pepia John CPrincipal Accounting Officer
|
Exercise / conversionCommon Stock | 3,000 | $27.72 | $83,145.00 |
DisclosureSEC source: 0001209191-18-032649 · doc4.xml · nonDerivative · entry 1 Pepia John C · CIK 0001674717 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,716 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 21, 2018 Filed May 23, 2018 20:55 UTC |
Lopez-Blanco VivianChief Financial Officer
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 40,000 | $25.14 Strike: $25.14 | $1,005,600.00 |
DisclosureSEC source: 0001209191-18-032648 · doc4.xml · derivative · entry 3 Lopez-Blanco Vivian · CIK 0001479017 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 40,000 shares Expires 2018-05-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 21, 2018 Filed May 23, 2018 20:55 UTC |
Lopez-Blanco VivianChief Financial Officer
|
Tax withholdingCommon Stock | 26,058 | $46.60 | $1,214,302.80 |
DisclosureSEC source: 0001209191-18-032648 · doc4.xml · nonDerivative · entry 2 Lopez-Blanco Vivian · CIK 0001479017 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,927.24 F1 · kind: Represents a "net exercise" of outstanding stock options. The reporting person received 13,942 shares of common stock upon the net exercise of 40,000 stock options with 26,058 shares withheld for payment of the exercise price and taxes, based on the market price of Issuer's common stock at the time of the option exercise. Read SEC document |
| May 21, 2018 Filed May 23, 2018 20:55 UTC |
Lopez-Blanco VivianChief Financial Officer
|
Exercise / conversionCommon Stock | 40,000 | $25.14 | $1,005,600.00 |
DisclosureSEC source: 0001209191-18-032648 · doc4.xml · nonDerivative · entry 1 Lopez-Blanco Vivian · CIK 0001479017 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,985.24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 04, 2018 Filed May 8, 2018 21:01 UTC |
ALVAREZ CESAR LDirector
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 10,668 | $27.72 Strike: $27.72 | $295,663.62 |
DisclosureSEC source: 0001209191-18-028634 · doc4.xml · derivative · entry 3 ALVAREZ CESAR L · CIK 0001220297 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,668 shares Expires 2018-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.expiration_date: Stock Options were due to expire on May 23, 2018. Read SEC document |
| May 04, 2018 Filed May 8, 2018 21:01 UTC |
ALVAREZ CESAR LDirector
|
Tax withholdingCommon Stock | 6,578 | $44.95 | $295,681.10 |
DisclosureSEC source: 0001209191-18-028634 · doc4.xml · nonDerivative · entry 2 ALVAREZ CESAR L · CIK 0001220297 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,987 F1 · kind: Represents a "net exercise" of outstanding stock options. The reporting person received 4,090 shares of common stock upon the net exercise of 10,668 stock options with 6,578 shares withheld for payment of the exercise price, based on the market price of Issuer's common stock at the time of the option exercise. Read SEC document |
| May 04, 2018 Filed May 8, 2018 21:01 UTC |
ALVAREZ CESAR LDirector
|
Exercise / conversionCommon Stock | 10,668 | $27.72 | $295,663.62 |
DisclosureSEC source: 0001209191-18-028634 · doc4.xml · nonDerivative · entry 1 ALVAREZ CESAR L · CIK 0001220297 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,565 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 19, 2018 Filed Mar 20, 2018 20:36 UTC |
SOSA ENRIQUEDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 10,668 | $27.72 Strike: $27.72 | $295,663.62 |
DisclosureSEC source: 0001209191-18-020883 · doc4.xml · derivative · entry 3 SOSA ENRIQUE · CIK 0001219818 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,668 shares Expires 2018-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 19, 2018 Filed Mar 20, 2018 20:36 UTC |
SOSA ENRIQUEDirector
|
Tax withholdingCommon Stock | 5,259 | $56.23 | $295,713.57 |
DisclosureSEC source: 0001209191-18-020883 · doc4.xml · nonDerivative · entry 2 SOSA ENRIQUE · CIK 0001219818 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,306 F1 · kind: Represents a "net exercise" of outstanding stock options. The reporting person received 5,409 shares of common stock upon the net exercise of 10,668 stock options with 5,259 shares withheld for payment of the exercise price, based on the market price of Issuer's common stock at the time of the option exercise. Read SEC document |
| March 19, 2018 Filed Mar 20, 2018 20:36 UTC |
SOSA ENRIQUEDirector
|
Exercise / conversionCommon Stock | 10,668 | $27.72 | $295,663.62 |
DisclosureSEC source: 0001209191-18-020883 · doc4.xml · nonDerivative · entry 1 SOSA ENRIQUE · CIK 0001219818 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,565 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 13, 2018 Filed Mar 14, 2018 21:05 UTC |
Pepia John CPrincipal Accounting Officer
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 3,000 | $27.72 Strike: $27.72 | $83,145.00 |
DisclosureSEC source: 0001209191-18-019619 · doc4.xml · derivative · entry 3 Pepia John C · CIK 0001674717 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 Underlying: Common Stock · 3,000 shares Expires 2018-06-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 13, 2018 Filed Mar 14, 2018 21:05 UTC |
Pepia John CPrincipal Accounting Officer
|
SaleCommon Stock | 3,000 | $58.35 | $175,062.60 |
DisclosureSEC source: 0001209191-18-019619 · doc4.xml · nonDerivative · entry 2 Pepia John C · CIK 0001674717 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,716 F1 · kind: Sales made pursuant to Reporting Person's 105b-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in sixteen (16) separate transactions with prices ranging from $57.85 to $58.79 for a weighted average sales price of $58.3542. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares at each separate price within the range set forth in this footnote. Read SEC document |
| March 13, 2018 Filed Mar 14, 2018 21:05 UTC |
Pepia John CPrincipal Accounting Officer
|
Exercise / conversionCommon Stock | 3,000 | $27.72 | $83,145.00 |
DisclosureSEC source: 0001209191-18-019619 · doc4.xml · nonDerivative · entry 1 Pepia John C · CIK 0001674717 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,716 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2018 Filed Mar 2, 2018 22:07 UTC |
SOSA ENRIQUEDirector
|
GrantCommon Stock | 2,350 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-015799 · doc4.xml · nonDerivative · entry 1 SOSA ENRIQUE · CIK 0001219818 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,897 F1 · shares: Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. Shares will vest in three equal installments on March 1, 2019, March 1, 2020 and March 1, 2021. Read SEC document |
| March 01, 2018 Filed Mar 2, 2018 22:06 UTC |
MEDEL ROGER MDDirector · Chief Executive Officer
|
GrantCommon Stock | 147,439 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-015794 · doc4.xml · nonDerivative · entry 1 MEDEL ROGER MD · CIK 0001093125 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,436,178 F1 · shares: Restricted shares granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. The number of shares being reported represents the "target" number of restricted shares and does not include the right of the reporting person to receive up to 36,860 additional shares based on the achievement of certain performance-based criteria for the twelve months ended December 31, 2018. The actual number of shares earned could be less than or greater than the target number, depending on the level of performance achieved, and all of the restricted shares granted are subject to forfeiture if minimum levels of performance are not met. Any restricted shares earned will vest in three equal installments on March 1, 2019, March 1, 2020 and March 1, 2021. Read SEC document |
| March 01, 2018 Filed Mar 2, 2018 22:07 UTC |
SHALALA DONNA EDirector
|
GrantCommon Stock | 2,350 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-015798 · doc4.xml · nonDerivative · entry 1 SHALALA DONNA E · CIK 0001140422 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,947 F1 · shares: Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. Shares will vest in three equal installments on March 1, 2019, March 1, 2020 and March 1, 2021. Read SEC document |
| March 01, 2018 Filed Mar 2, 2018 22:06 UTC |
Pepia John CPrincipal Accounting Officer
|
GrantCommon Stock | 4,147 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-015797 · doc4.xml · nonDerivative · entry 1 Pepia John C · CIK 0001674717 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,716 F1 · shares: Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. The vesting of the restricted shares is subject to performance-based criteria with any shares earned vesting in three equal installments on March 1, 2019, March 1, 2020 and March 1, 2021. Read SEC document |
| March 01, 2018 Filed Mar 2, 2018 22:05 UTC |
Lopez-Blanco VivianChief Financial Officer
|
GrantCommon Stock | 36,860 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-015793 · doc4.xml · nonDerivative · entry 1 Lopez-Blanco Vivian · CIK 0001479017 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,985.24 F1 · shares: Restricted shares granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. The number of shares being reported represents the "target" number of restricted shares and does not include the right of the reporting person to receive up to 9,215 additional shares based on the achievement of certain performance-based criteria for the twelve months ended December 31, 2018. The actual number of shares earned could be less than or greater than the target number, depending on the level of performance achieved, and all of the restricted shares granted are subject to forfeiture if minimum levels of performance are not met. Any restricted shares earned will vest in three equal installments on March 1, 2019, March 1, 2020 and March 1, 2021. Read SEC document |
| March 01, 2018 Filed Mar 2, 2018 22:02 UTC |
Kadre ManuelDirector
|
GrantCommon Stock | 2,350 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-015786 · doc4.xml · nonDerivative · entry 1 Kadre Manuel · CIK 0001396538 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,897 F1 · shares: Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. Shares will vest in three equal installments on March 1, 2019, March 1, 2020 and March 1, 2021. Read SEC document |
| March 01, 2018 Filed Mar 2, 2018 22:01 UTC |
Goldschmidt, MD Pascal JDirector
|
GrantCommon Stock | 2,350 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-015784 · doc4.xml · nonDerivative · entry 1 Goldschmidt, MD Pascal J · CIK 0001356123 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,422 F1 · shares: Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. Shares will vest in three equal installments on March 1, 2019, March 1, 2020 and March 1, 2021. Read SEC document |
| March 01, 2018 Filed Mar 2, 2018 22:01 UTC |
GABOS PAUL GDirector
|
GrantCommon Stock | 2,350 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-015782 · doc4.xml · nonDerivative · entry 1 GABOS PAUL G · CIK 0001216803 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,897 F1 · shares: Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. Shares will vest in three equal installments on March 1, 2019, March 1, 2020 and March 1, 2021. Read SEC document |
| March 01, 2018 Filed Mar 2, 2018 22:00 UTC |
FERNANDEZ MICHAELDirector
|
GrantCommon Stock | 2,350 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-015780 · doc4.xml · nonDerivative · entry 1 FERNANDEZ MICHAEL · CIK 0001218838 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,589 F1 · shares: Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. Shares will vest in three equal installments on March 1, 2019, March 1, 2020 and March 1, 2021. Read SEC document |
| March 01, 2018 Filed Mar 2, 2018 22:00 UTC |
Clark David A.Pres. Mednax Natl Med Group
|
GrantCommon Stock | 19,352 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-015777 · doc4.xml · nonDerivative · entry 1 Clark David A. · CIK 0001443082 · Pres. Mednax Natl Med Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,452 F1 · shares: Restricted shares granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. The number of shares being reported represents the "target" number of restricted shares and does not include the right of the reporting person to receive up to 4,838 additional shares based on the achievement of certain performance-based criteria for the twelve months ended December 31, 2018. The actual number of shares earned could be less than or greater than the target number, depending on the level of performance achieved, and all of the restricted shares granted are subject to forfeiture if minimum levels of performance are not met. Any restricted shares earned will vest in three equal installments on March 1, 2019, March 1, 2020 and March 1, 2021. Read SEC document |
| March 01, 2018 Filed Mar 2, 2018 21:59 UTC |
WALDEMAR, MD CARLO ADirector
|
GrantCommon Stock | 2,350 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-015774 · doc4.xml · nonDerivative · entry 1 WALDEMAR, MD CARLO A · CIK 0001218839 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,897 F1 · shares: Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. Shares will vest in three equal installments on March 1, 2019, March 1, 2020 and March 1, 2021. Read SEC document |
| March 01, 2018 Filed Mar 2, 2018 21:59 UTC |
CALABRO JOSEPH MPresident and COO
|
GrantCommon Stock | 92,149 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-015773 · doc4.xml · nonDerivative · entry 1 CALABRO JOSEPH M · CIK 0001218834 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 354,933 F1 · shares: Restricted shares granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. The number of shares being reported represents the "target" number of restricted shares and does not include the right of the reporting person to receive up to 23,037 additional shares based on the achievement of certain performance-based criteria for the twelve months ended December 31, 2018. The actual number of shares earned could be less than or greater than the target number, depending on the level of performance achieved, and all of the restricted shares granted are subject to forfeiture if minimum levels of performance are not met. Any restricted shares earned will vest in three equal installments on March 1, 2019, March 1, 2020 and March 1, 2021. Read SEC document |
| March 01, 2018 Filed Mar 2, 2018 21:59 UTC |
Barker Karey DDirector
|
GrantCommon Stock | 2,350 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-015772 · doc4.xml · nonDerivative · entry 1 Barker Karey D · CIK 0001641573 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,362 F1 · shares: Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. Shares will vest in three equal installments on March 1, 2019, March 1, 2020 and March 1, 2021. Read SEC document |
| March 01, 2018 Filed Mar 2, 2018 21:58 UTC |
Andreano Dominic JSVP, General Counsel and Secy
|
GrantCommon Stock | 13,823 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-015769 · doc4.xml · nonDerivative · entry 1 Andreano Dominic J · CIK 0001549694 · SVP, General Counsel and Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,039.22 F1 · shares: Restricted shares granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. The number of shares being reported represents the "target" number of restricted shares and does not include the right of the reporting person to receive up to 3,456 additional shares based on the achievement of certain performance-based criteria for the twelve months ended December 31, 2018. The actual number of shares earned could be less than or greater than the target number, depending on the level of performance achieved, and all of the restricted shares granted are subject to forfeiture if minimum levels of performance are not met. Any restricted shares earned will vest in three equal installments on March 1, 2019, March 1, 2020 and March 1, 2021. Read SEC document |
| March 01, 2018 Filed Mar 2, 2018 21:57 UTC |
ALVAREZ CESAR LDirector
|
GrantCommon Stock | 2,350 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-015766 · doc4.xml · nonDerivative · entry 1 ALVAREZ CESAR L · CIK 0001220297 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,897 F1 · acquired: Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. Shares will vest in three equal installments on March 1, 2019, March 1, 2020 and March 1, 2021. Read SEC document |
| December 12, 2017 Filed Dec 12, 2017 21:48 UTC |
Pepia John CPrincipal Accounting Officer
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 3,000 | $27.72 Strike: $27.72 | $83,145.00 |
DisclosureSEC source: 0001209191-17-065215 · doc4.xml · derivative · entry 3 Pepia John C · CIK 0001674717 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Common Stock · 3,000 shares Expires 2018-06-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 12, 2017 Filed Dec 12, 2017 21:48 UTC |
Pepia John CPrincipal Accounting Officer
|
SaleCommon Stock | 3,000 | $51.58 | $154,740.00 |
DisclosureSEC source: 0001209191-17-065215 · doc4.xml · nonDerivative · entry 2 Pepia John C · CIK 0001674717 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,569 Read SEC document |
| December 12, 2017 Filed Dec 12, 2017 21:48 UTC |
Pepia John CPrincipal Accounting Officer
|
Exercise / conversionCommon Stock | 3,000 | $27.72 | $83,145.00 |
DisclosureSEC source: 0001209191-17-065215 · doc4.xml · nonDerivative · entry 1 Pepia John C · CIK 0001674717 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,569 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 07, 2017 Filed Dec 8, 2017 22:35 UTC |
Clark David A.Pres. Mednax Natl Med Group
|
GrantRestricted Shares Units · Derivative | 14,741 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-064791 · doc4.xml · derivative · entry 1 Clark David A. · CIK 0001443082 · Pres. Mednax Natl Med Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,741 Underlying: Common Stock · 14,741 shares Expires 2020-05-15 F1 · security: Restricted Shares Units, or Deferred Stock, granted under the Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended. F2 · derivative.exercise_price: Each Restricted Share Unit represents the equivalent of one share of Issuer's Common Stock. F3 · derivative.exercise_date: Restricted Shares Units become payable in shares of Issuer's Common Stock and will vest after satisfaction of certain performance-based and time-based criteria. Read SEC document |
| December 07, 2017 Filed Dec 8, 2017 22:36 UTC |
Andreano Dominic JSVP, General Counsel and Secy
|
GrantRestricted Shares Units · Derivative | 9,828 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-064792 · doc4.xml · derivative · entry 1 Andreano Dominic J · CIK 0001549694 · SVP, General Counsel and Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,828 Underlying: Common Stock · 9,828 shares Expires 2020-05-15 F1 · security: Restricted Shares Units, or Deferred Stock, granted under the Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended. F2 · derivative.exercise_price: Each Restricted Share Unit represents the equivalent of one share of Issuer's Common Stock. F3 · derivative.exercise_date: Restricted Shares Units become payable in shares of Issuer's Common Stock and will vest after satisfaction of certain performance-based and time-based criteria. Read SEC document |
| December 07, 2017 Filed Dec 8, 2017 22:34 UTC |
Pepia John CPrincipal Accounting Officer
|
GrantRestricted Shares Units · Derivative | 7,862 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-064790 · doc4.xml · derivative · entry 1 Pepia John C · CIK 0001674717 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,862 Underlying: Common Stock · 7,862 shares Expires 2020-05-15 F1 · security: Restricted Shares Units, or Deferred Stock, granted under the Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended. F2 · derivative.exercise_price: Each Restricted Share Unit represents the equivalent of one share of Issuer's Common Stock. F3 · derivative.exercise_date: Restricted Shares Units become payable in shares of Issuer's Common Stock and will vest after satisfaction of certain performance-based and time-based criteria. Read SEC document |
| November 03, 2017 Filed Nov 3, 2017 20:44 UTC |
ALVAREZ CESAR LDirector
|
SaleCommon Stock | 10,668 | $42.59 | $454,374.66 |
DisclosureSEC source: 0001209191-17-059188 · doc4.xml · nonDerivative · entry 2 ALVAREZ CESAR L · CIK 0001220297 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,547 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in twenty-nine (29) separate transactions with prices ranging from $42.35 to $42.81 for an average weighted sales price of $42.5923. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 01, 2017 Filed Nov 3, 2017 20:44 UTC |
ALVAREZ CESAR LDirector
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 10,668 | $32.33 Strike: $32.33 | $344,843.10 |
DisclosureSEC source: 0001209191-17-059188 · doc4.xml · derivative · entry 3 ALVAREZ CESAR L · CIK 0001220297 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,668 shares Expires 2017-11-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 01, 2017 Filed Nov 3, 2017 20:44 UTC |
ALVAREZ CESAR LDirector
|
Exercise / conversionCommon Stock | 10,668 | $32.33 | $344,843.10 |
DisclosureSEC source: 0001209191-17-059188 · doc4.xml · nonDerivative · entry 1 ALVAREZ CESAR L · CIK 0001220297 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,215 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 12, 2017 Filed Sep 13, 2017 21:11 UTC |
Pepia John CPrincipal Accounting Officer
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 3,000 | $27.72 Strike: $27.72 | $83,145.00 |
DisclosureSEC source: 0001209191-17-052647 · doc4.xml · derivative · entry 3 Pepia John C · CIK 0001674717 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,000 Underlying: Common Stock · 3,000 shares Expires 2018-06-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 12, 2017 Filed Sep 13, 2017 21:11 UTC |
Pepia John CPrincipal Accounting Officer
|
SaleCommon Stock | 3,000 | $42.85 | $128,550.00 |
DisclosureSEC source: 0001209191-17-052647 · doc4.xml · nonDerivative · entry 2 Pepia John C · CIK 0001674717 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,569 Read SEC document |
| September 12, 2017 Filed Sep 13, 2017 21:11 UTC |
Pepia John CPrincipal Accounting Officer
|
Exercise / conversionCommon Stock | 3,000 | $27.72 | $83,145.00 |
DisclosureSEC source: 0001209191-17-052647 · doc4.xml · nonDerivative · entry 1 Pepia John C · CIK 0001674717 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,569 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 14, 2017 Filed Jun 14, 2017 20:51 UTC |
Goldschmidt, MD Pascal JDirector
|
SaleCommon Stock | 1,969 | $57.57 | $113,355.33 |
DisclosureSEC source: 0001209191-17-039857 · doc4.xml · nonDerivative · entry 1 Goldschmidt, MD Pascal J · CIK 0001356123 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,072 Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 20:45 UTC |
SOSA ENRIQUEDirector
|
GrantCommon Stock | 2,292 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-037329 · doc4.xml · nonDerivative · entry 1 SOSA ENRIQUE · CIK 0001219818 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,547 F1 · shares: Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. Shares will vest in three equal installments on June 1, 2018, June 1, 2019 and June 1, 2020. Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 20:44 UTC |
Pepia John CPrincipal Accounting Officer
|
GrantCommon Stock | 4,044 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-037325 · doc4.xml · nonDerivative · entry 1 Pepia John C · CIK 0001674717 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,569 F1 · shares: Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. The vesting of the restricted shares is subject to performance based criteria but will not vest any earlier than in three equal installments on June 1, 2018, June 1, 2019 and June 1, 2020. Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 20:44 UTC |
SHALALA DONNA EDirector
|
GrantCommon Stock | 2,292 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-037326 · doc4.xml · nonDerivative · entry 1 SHALALA DONNA E · CIK 0001140422 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,597 F1 · shares: Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. Shares will vest in three equal installments on June 1, 2018, June 1, 2019 and June 1, 2020. Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 20:43 UTC |
MEDEL ROGER MDDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 38,257 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-037322 · doc4.xml · nonDerivative · entry 3 MEDEL ROGER MD · CIK 0001093125 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,288,739 F3 · balance_after: Reflects a reduction of 16,840 in previously reported target shares that were granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with achievement of specified performance-based criteria below target for the performance period from April 1, 2016 through March 31, 2017. The decrease in restricted shares impacts the installments vesting on June 1, 2017, June 1, 2018 and June 1, 2019. The vesting of such shares remains subject to continued employment. Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 20:43 UTC |
MEDEL ROGER MDDirector · Chief Executive Officer
|
GrantCommon Stock | 110,532 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-037322 · doc4.xml · nonDerivative · entry 2 MEDEL ROGER MD · CIK 0001093125 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,343,836 F2 · shares: Restricted shares granted pursuant to the Issuer's Amended and Restate 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. The number of shares being reported represents the "target" number of restricted shares and does not include the right of the reporting person to receive up to 27,633 additional shares based on the achievement of certain performance-based criteria for the period from April 1, 2017 through March 31, 2018. The actual number of shares earned could be less than or greater than the target number, depending on the level of performance achieved, and all of the restricted shares granted are subject to forfeiture if minimum levels of performance are not met. Any restricted shares earned will not vest any earlier than in three equal installments on June 1, 2018, June 1, 2019 and June 1, 2020. Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 20:42 UTC |
Lopez-Blanco VivianChief Financial Officer
|
GrantCommon Stock | 23,365 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-037318 · doc4.xml · nonDerivative · entry 1 Lopez-Blanco Vivian · CIK 0001479017 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,125.24 F1 · shares: Restricted shares granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. The number of shares being reported represents the "target" number of restricted shares and does not include the right of the reporting person to receive up to 5,841 additional shares based on the achievement of certain performance-based criteria for the period from April 1, 2017 through March 31, 2018. The actual number of shares earned could be less than or greater than the target number, depending on the level of performance achieved, and all of the restricted shares granted are subject to forfeiture if minimum levels of performance are not met. Any restricted shares earned will not vest any earlier than in three equal installments on June 1, 2018, June 1, 2019 and June 1, 2020. F2 · balance_after: Reflects a reduction of 3,559 in previously reported target shares that were granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with achievement of specified performance-based criteria below target for the performance period from April 1, 2016 through March 31, 2017. The decrease in restricted shares impacts the installments vesting on June 1, 2017, June 1, 2018 and June 1, 2019. The vesting of such shares remains subject to continued employment. Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 20:42 UTC |
Kadre ManuelDirector
|
GrantCommon Stock | 2,292 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-037315 · doc4.xml · nonDerivative · entry 1 Kadre Manuel · CIK 0001396538 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,547 F1 · shares: Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. Shares will vest in three equal installments on June 1, 2018, June 1, 2019 and June 1, 2020. Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 20:41 UTC |
Goldschmidt, MD Pascal JDirector
|
GrantCommon Stock | 2,292 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-037312 · doc4.xml · nonDerivative · entry 1 Goldschmidt, MD Pascal J · CIK 0001356123 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,041 F1 · shares: Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. Shares will vest in three equal installments on June 1, 2018, June 1, 2019 and June 1, 2020. Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 20:41 UTC |
GABOS PAUL GDirector
|
GrantCommon Stock | 2,292 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-037306 · doc4.xml · nonDerivative · entry 1 GABOS PAUL G · CIK 0001216803 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,547 F1 · shares: Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. Shares will vest in three equal installments on June 1, 2018, June 1, 2019 and June 1, 2020. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.